Colin Lightfoot

B.Sc. Biomedical Science, M.Sc. Infection and Immunity

Colin graduated from the University of Chester with a B.Sc. in Biomedical Science in 2020. Since completing his undergraduate degree, he worked for NHS England as an Associate Practitioner, responsible for testing inpatients for COVID-19 on admission.

Recently Colin was a Study Assistant for Perfectus Biomed, where he grew cell lines and viruses for the testing of mainly commercial cleaning products. He recently completed an M.Sc. in Infection and Immunity at The University of Chester, where his main research focus was antibiotic resistance and the possibility of combatting this with bacteriophage therapy.

See less

Articles from Colin

How capable are children to self-swab for SARS-CoV-2?

Researchers gather data that supports the evidence-based recommendations for children to successfully perform nasal swabs on themselves.

15 Mar 2022

Study considers factors contributing to health-related quality of life in adolescents during the COVID-19 pandemic

Researchers from the University of Jerusalem investigated the health-related quality of life of adolescents before and during the pandemic.

15 Mar 2022

Sporadic Legionnaires’ disease in commercial truck drivers could be attributed to vehicle windshield wiper fluid

A new study examines two cases of Legionnaires’ disease diagnosed via urine antigen test that were reported and linked to windshield wiper fluid contaminated with Legionella spp.

10 Mar 2022

CRIPSR identifies cell-type-specific ACE2 modifiers

Researchers compile a list of candidate genes to identify the surface abundance of functional regulators of ACE2.

9 Mar 2022

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

A new study examined a unique case of extended viral shedding in an immunocompromised patient that produced a series of SARS-CoV-2 immune escape mutations over a seven-month period.

8 Mar 2022

French study shows COVID vaccine efficacy 94% against severe outcomes

A recent paper published on the medRxiv preprint server utilized data from three national databases containing an abundance of information on Covid-19 screening (SI-DEP), vaccination (VAC-SI), and hospitalizations (SI-VIC) in France to provide additional perspectives on vaccine effectiveness and its evolution over the year 2021 in the French context.

7 Mar 2022